Related references
Note: Only part of the references are listed.Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes
Lutgarda Bozzetto et al.
ATHEROSCLEROSIS (2011)
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Hyohun Park et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet
Tomonori Muraoka et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
Dick C. Chan et al.
DIABETES CARE (2010)
Ezetimibe Ameliorates Metabolic Disorders and Microalbuminuria in Patients with Hypercholesterolemia
Shusuke Yagi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Molecular Mechanisms of Ezetimibe-Induced Attenuation of Postprandial Hypertriglyceridemia
Jose C. Sandoval et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice
Masaya Fukuda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Hypercholesterolemia Treatment Patterns and Low-Density Lipoprotein Cholesterol Monitoring in Patients with a Diagnosis of Atherosclerosis in Clinical Practice
Michael H. Davidson et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis
Heather Basciano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
D. Masuda et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia
Andre J. Tremblay et al.
JOURNAL OF LIPID RESEARCH (2009)
Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice
Eric D. Labonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Intestinally derived lipids: Metabolic regulation and consequences - An overview
Katherine Cianflone et al.
ATHEROSCLEROSIS SUPPLEMENTS (2008)
Postprandial dyslipidemia in insulin resistance: Mechanisms and role of intestinal insulin sensitivity
Joanne Hsieh et al.
ATHEROSCLEROSIS SUPPLEMENTS (2008)
Effect of ezetimibe on plasma cholesterol levels, cholesterol absorption, and secretion of biliary cholesterol in laboratory opossums with high and low responses to dietary cholesterol
Jeannie Chan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
Michiyo Deushi et al.
FEBS LETTERS (2007)
Deficiency of Niemann-Pick C1 like 1 prevents atherosclerosis in ApoE-/- mice
Harry R. Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Ezetimibe inhibits the incorporation of dietary oxidized cholesterol into lipoproteins
Ilona Staprans et al.
JOURNAL OF LIPID RESEARCH (2006)
Effect of Ezetimibe on the in vivo kinetics of ApoB-48 and ApoB-100 in men with primary hypercholesterolemia
AJ Tremblay et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Effect of ezetimibe on insulin sensitivity and lipid profile in obese and dyslipidaemic patients
Manuel Gonzalez-Ortiz et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: Evidence for induction by insulin resistance and exogenous fatty acids
QS Guo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption
JJ Repa et al.
JOURNAL OF LIPID RESEARCH (2005)
Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: Studies in insulin-resistant and insulin-sensitized Syrian Golden hamsters
GF Lewis et al.
ENDOCRINOLOGY (2004)
Fatty acid flux suppresses fatty acid synthesis in hamster intestine independently of SREBP-1 expression
FJ Field et al.
JOURNAL OF LIPID RESEARCH (2003)
Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
RH Knopp et al.
EUROPEAN HEART JOURNAL (2003)
Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance -: Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction
M Haidari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function
M van Heek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters
M van Heek et al.
DIABETES (2001)
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys
M van Heek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Postprandial metabolism of apolipoprotein B-48-and B-100-containing particles in type 2 diabetes mellitus:: relations to angiographically verified severity of coronary artery disease
N Mero et al.
ATHEROSCLEROSIS (2000)
Share Paper
